LOS GATOS, CA / ACCESS Newswire / July 30, 2026 / Tenon Medical, Inc. (NASDAQ:TNON)(&#34;Tenon&#34; or the &#34;Company&#34;), a medical device company dedicated to transforming care for patients with certain

<p><strong id="dateline">LOS GATOS, CA / <a href='https://www.accessnewswire.com/'>ACCESS Newswire</a> / July 30, 2026 / </strong><a rel="nofollow" href="https://pr.report/odfx"><u>Tenon Medical, Inc.</u></a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/TNON">TNON</a>)("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders, today announced plans to release financial results for the second quarter ended June 30, 2026 after market close on Thursday, August 13, 2026. The Company will also hold a conference call on the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with its covering analysts.</p><table style="width:6.75in"><tbody><tr><td style="padding:0in 5.4pt;vertical-align:top;width:175.5pt;"><p><strong>Date:</strong></p></td><td style="padding:0in 5.4pt;vertical-align:top;width:310.5pt;"><p>Thursday, August 13, 2026</p></td></tr><tr><td style="padding:0in 5.4pt;vertical-align:top;width:175.5pt;"><p><strong>Time:</strong></p></td><td style="padding:0in 5.4pt;vertical-align:top;width:310.5pt;"><p>4:30 p.m. Eastern time</p></td></tr><tr><td style="padding:0in 5.4pt;vertical-align:top;width:175.5pt;"><p><strong>Dial-in:</strong></p></td><td style="padding:0in 5.4pt;vertical-align:top;width:310.5pt;"><p>1-877-407-0792</p></td></tr><tr><td style="padding:0in 5.4pt;vertical-align:top;width:175.5pt;"><p><strong>International Dial-in:</strong></p></td><td style="padding:0in 5.4pt;vertical-align:top;width:310.5pt;"><p>1-201-689-8263</p></td></tr><tr><td style="height:3.5pt;padding:0in 5.4pt;vertical-align:top;width:175.5pt;"><p><strong>Webcast:</strong></p></td><td style="height:3.5pt;padding:0in 5.4pt;vertical-align:top;width:310.5pt;"><p><a rel="nofollow" href="https://pr.report/odg1">TNON Conference Call</a><br/> </p></td></tr></tbody></table><div><p>Please dial in at least 10 minutes before the start of the call to ensure timely participation.</p></div><p>An audio playback of the call will be available through August 27, 2026,on Tenon's Investor Relations website at <a rel="nofollow" href="https://pr.report/odfz"><u>http://ir.tenonmed.com/</u></a> or via telephone replay by dialing 1-844-512-2921 (USA) or 1-412-317-6671(International). The access code will be 13761819.</p><p><strong>About Tenon Medical, Inc.</strong></p><a href="https://app.accessnewswire.com/imagelibrary/7b4d1deb-7e7c-4379-937a-cfaad6eef51c/1198665/picture4.jpg" rel="nofollow"><img src="https://app.accessnewswire.com/imagelibrary/7b4d1deb-7e7c-4379-937a-cfaad6eef51c/1198665/picture4.jpg" width="113" style="text-align:center;margin:0.9em auto;"></a><div> </div><div> </div><div> </div><div> </div><p>Tenon Medical, Inc. is a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders. Tenon was incorporated in the State of Delaware in 2012 and currently offers two systems to treat a diseased sacroiliac joint (the "SI Joint"). The Company has developed The Catamaran<sup>&#8482;</sup> SI Joint Fusion System that offers a novel, less invasive approach to the SI Joint using a single, robust titanium implant. In August 2025, the Company acquired substantially allof the assets of SiVantage, Inc. and SIMPL Medical, LLC, including the SImmetry+<sup>&#174;</sup> SI Joint Fusion System, which treats disorders of the SI Joint through a minimally invasive lateral access solution that incorporates well-established orthopedic fusion principles. Since the national launch of The Catamaran System in October 2022, Tenon is focused on three commercial opportunities: 1) primary SI Joint procedures, 2) revision procedures of failed SI Joint implants and 3) SI-Joint fusion adjunct to a spine fusion construct.</p><p>For more information, please visit <a rel="nofollow" href="https://pr.report/odg0"><u>www.tenonmed.com</u></a>. Information on the Company's website does not constitute a part of and is not incorporated by reference into this press release.</p><p><i>The Tenon Medical logo shown above, and Catamaran<sup>&#174;</sup>, PiSIF<sup>&#174;</sup>, CAT PiSIF<sup>&#174;</sup>, ETAD<sup>&#174;</sup>, Posterior Inferior Sacroiliac Fusion<sup>&#174;</sup>, CAT SIJ Fusion System<sup>&#174;</sup>, Catamaran SIJ Fusion System<sup>&#174;</sup>, Catamaran Inferior Posterior Fusion System<sup>&#174;</sup>, Catamaran Transfixation Fusion System<sup>&#174;</sup>, Catamaran Transfixation Fusion Device<sup>&#174;</sup>, SImmetry<sup>&#174;</sup> are registered trademarks of Tenon Medical, Inc. MAINSAIL<sup>TM</sup>, and SImmetry+ are also trademarks of Tenon Medical, Inc.</i></p><p><strong>IR Contact:</strong><br/>Shannon Devine<br/>203-741-8811<br/>MZ North America<br/><a rel="nofollow" href="mailto:tenon@mzgroup.us"><u>tenon@mzgroup.us</u></a></p><p><strong>SOURCE: </strong>Tenon Medical, Inc.</p><br/><br/>View the original <a href='https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/tenon-medical-inc.-sets-date-for-second-quarter-2026-earnings-1198665'>press release</a> on ACCESS Newswire<br/><br/>
      <img src="https://app.accessnewswire.com/img.ashx?id=1198665" width="0" height="0"/>

TNON

Tenon Medical, Inc. Sets Date for Second Quarter 2026 Earnings

Tenon Medical schedules Q2 2026 earnings release for Aug 13

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>LOS GATOS, CA / ACCESS Newswire / July 30, 2026 / Tenon Medical, Inc. (NASDAQ:TNON)(&amp;#34;Tenon&amp;#34; or the &amp;#34;Company&amp;#34;), a medical device company dedicated to transforming care for patients with certain</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>Tenon Medical announced its Q2 2026 results will be released after market close on Aug 13, 2026, with a conference call at 4:30 PM ET. The notice highlights the company’s expanded sacro-pelvic joint portfolio following Aug 2025 acquisitions of SiVantage and SIMPL Medical, potentially informing investor sentiment though no guidance is provided. The press release sets expectations for near-term event-driven activity around the earnings release date.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>Tenon sets Q2 2026 earnings date for Aug 13 after hours.</li><li>Conference call at 4:30 PM ET with dial-in and webcast details.</li><li>Tenon expanded SIJ portfolio via Aug 2025 SiVantage and SIMPL Medical acquisitions.</li><li>Notice provides schedule but no financial figures or guidance.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>Tenon Medical, Inc. (TNON)</strong>: Announces Q2 2026 earnings date and conference call; primary price driver near Aug 13 event.</li><li><strong>SiVantage, Inc. (N/A)</strong>: Acquired assets in Aug 2025; expands SIJ product portfolio post-acquisition.</li><li><strong>SIMPL Medical, LLC (N/A)</strong>: Acquired Aug 2025; adds SImmetry+ SIJ Fusion capabilities to Tenon’s lineup.</li></ul>
  </section>

  <section data-block="category">
    <h3>Earnings</h3>
    <p>Category: Earnings. The article is a standard earnings-date notice; relevance centers on timing for TNON&#039;s next quarterly results and potential near-term volatility around the update.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>Earnings date for Aug 13 could trigger short-term volatility in TNON.</li><li>Lack of guidance in the release limits immediate upside; depends on results.</li><li>Acquisitions of SiVantage and SIMPL Medical may support longer-term revenue prospects.</li><li>Product portfolio focus on Catamaran and SImmetry+ could influence demand expectations.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>Earnings release date: August 13, 2026 after market close.</li><li>Conference call time: 4:30 p.m. Eastern Time.</li><li>Dial-in numbers: 1-877-407-0792 (US), International: 1-201-689-8263.</li><li>Audio playback available through August 27, 2026 (code 13761819).</li><li>Company focus: sacroiliac joint disorders; Catamaran SIJ Fusion System and SImmetry+ products.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Neutral near-term; a positive earnings surprise could push TNON higher in the weeks after Aug 13.</p>
  </section>
</section>


<p><strong id="dateline">LOS GATOS, CA / <a href='https://www.accessnewswire.com/'>ACCESS Newswire</a> / July 30, 2026 / </strong><a rel="nofollow" href="https://pr.report/odfx"><u>Tenon Medical, Inc.</u></a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/TNON">TNON</a>)("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders, today announced plans to release financial results for the second quarter ended June 30, 2026 after market close on Thursday, August 13, 2026. The Company will also hold a conference call on the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with its covering analysts.</p><table style="width:6.75in"><tbody><tr><td style="padding:0in 5.4pt;vertical-align:top;width:175.5pt;"><p><strong>Date:</strong></p></td><td style="padding:0in 5.4pt;vertical-align:top;width:310.5pt;"><p>Thursday, August 13, 2026</p></td></tr><tr><td style="padding:0in 5.4pt;vertical-align:top;width:175.5pt;"><p><strong>Time:</strong></p></td><td style="padding:0in 5.4pt;vertical-align:top;width:310.5pt;"><p>4:30 p.m. Eastern time</p></td></tr><tr><td style="padding:0in 5.4pt;vertical-align:top;width:175.5pt;"><p><strong>Dial-in:</strong></p></td><td style="padding:0in 5.4pt;vertical-align:top;width:310.5pt;"><p>1-877-407-0792</p></td></tr><tr><td style="padding:0in 5.4pt;vertical-align:top;width:175.5pt;"><p><strong>International Dial-in:</strong></p></td><td style="padding:0in 5.4pt;vertical-align:top;width:310.5pt;"><p>1-201-689-8263</p></td></tr><tr><td style="height:3.5pt;padding:0in 5.4pt;vertical-align:top;width:175.5pt;"><p><strong>Webcast:</strong></p></td><td style="height:3.5pt;padding:0in 5.4pt;vertical-align:top;width:310.5pt;"><p><a rel="nofollow" href="https://pr.report/odg1">TNON Conference Call</a><br/> </p></td></tr></tbody></table><div><p>Please dial in at least 10 minutes before the start of the call to ensure timely participation.</p></div><p>An audio playback of the call will be available through August 27, 2026,on Tenon's Investor Relations website at <a rel="nofollow" href="https://pr.report/odfz"><u>http://ir.tenonmed.com/</u></a> or via telephone replay by dialing 1-844-512-2921 (USA) or 1-412-317-6671(International). The access code will be 13761819.</p><p><strong>About Tenon Medical, Inc.</strong></p><a href="https://app.accessnewswire.com/imagelibrary/7b4d1deb-7e7c-4379-937a-cfaad6eef51c/1198665/picture4.jpg" rel="nofollow"><img src="https://app.accessnewswire.com/imagelibrary/7b4d1deb-7e7c-4379-937a-cfaad6eef51c/1198665/picture4.jpg" width="113" style="text-align:center;margin:0.9em auto;"></a><div> </div><div> </div><div> </div><div> </div><p>Tenon Medical, Inc. is a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders. Tenon was incorporated in the State of Delaware in 2012 and currently offers two systems to treat a diseased sacroiliac joint (the "SI Joint"). The Company has developed The Catamaran<sup>&#8482;</sup> SI Joint Fusion System that offers a novel, less invasive approach to the SI Joint using a single, robust titanium implant. In August 2025, the Company acquired substantially allof the assets of SiVantage, Inc. and SIMPL Medical, LLC, including the SImmetry+<sup>&#174;</sup> SI Joint Fusion System, which treats disorders of the SI Joint through a minimally invasive lateral access solution that incorporates well-established orthopedic fusion principles. Since the national launch of The Catamaran System in October 2022, Tenon is focused on three commercial opportunities: 1) primary SI Joint procedures, 2) revision procedures of failed SI Joint implants and 3) SI-Joint fusion adjunct to a spine fusion construct.</p><p>For more information, please visit <a rel="nofollow" href="https://pr.report/odg0"><u>www.tenonmed.com</u></a>. Information on the Company's website does not constitute a part of and is not incorporated by reference into this press release.</p><p><i>The Tenon Medical logo shown above, and Catamaran<sup>&#174;</sup>, PiSIF<sup>&#174;</sup>, CAT PiSIF<sup>&#174;</sup>, ETAD<sup>&#174;</sup>, Posterior Inferior Sacroiliac Fusion<sup>&#174;</sup>, CAT SIJ Fusion System<sup>&#174;</sup>, Catamaran SIJ Fusion System<sup>&#174;</sup>, Catamaran Inferior Posterior Fusion System<sup>&#174;</sup>, Catamaran Transfixation Fusion System<sup>&#174;</sup>, Catamaran Transfixation Fusion Device<sup>&#174;</sup>, SImmetry<sup>&#174;</sup> are registered trademarks of Tenon Medical, Inc. MAINSAIL<sup>TM</sup>, and SImmetry+ are also trademarks of Tenon Medical, Inc.</i></p><p><strong>IR Contact:</strong><br/>Shannon Devine<br/>203-741-8811<br/>MZ North America<br/><a rel="nofollow" href="mailto:tenon@mzgroup.us"><u>tenon@mzgroup.us</u></a></p><p><strong>SOURCE: </strong>Tenon Medical, Inc.</p><br/><br/>View the original <a href='https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/tenon-medical-inc.-sets-date-for-second-quarter-2026-earnings-1198665'>press release</a> on ACCESS Newswire<br/><br/>
      <img src="https://app.accessnewswire.com/img.ashx?id=1198665" width="0" height="0"/>

Tenon Medical announced its Q2 2026 results will be released after market close on Aug 13, 2026, with a conference call at 4:30 PM ET. The notice highlights the company’s expanded sacro-pelvic joint portfolio following Aug 2025 acquisitions of SiVantage and SIMPL Medical, potentially informing investor sentiment though no guidance is provided. The press release sets expectations for near-term event-driven activity around the earnings release date.

News insight

Tenon Medical, Inc. Sets Date for Second Quarter 2026 Earnings

AI summary

Sentiment rationale

Key facts

Earnings